XML 26 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCKHOLDERS' EQUITY
 3 Months Ended
Apr. 28, 2024
Equity [Abstract]  
Stockholders' Equity STOCKHOLDERS' EQUITY
Stock Rollforward
The following table presents a reconciliation of the number of shares of our common stock outstanding and cash dividends per share:
shares in millionsThree Months Ended
April 28,
2024		April 30,
2023
Common stock:
Shares at beginning of period
1,796 1,794 
Shares issued under employee stock plans, net
2 1 
Shares at end of period
1,798 1,795 
Treasury stock:
Shares at beginning of period
(804)(778)
Repurchases of common stock(2)(10)
Shares at end of period
(806)(788)
Shares outstanding at end of period992 1,007 
Cash dividends per share$2.25 $2.09 
Share Repurchases
In August 2023, our Board of Directors approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $15.0 billion, which was approved in August 2022. The August 2023 authorization does not have a prescribed expiration date. As of April 28, 2024, approximately $11.7 billion of the $15.0 billion share repurchase authorization remained available. In March 2024, we paused share repurchases as a result of the pending acquisition of SRS (see Note 9).
The following table presents information about our repurchases of common stock, all of which were completed through open market purchases:
in millionsThree Months Ended
April 28,
2024		April 30,
2023
Total number of shares repurchased2 10 
Total cost of shares repurchased
$600 $3,028 

The cost of shares repurchased may differ from the repurchases of common stock amounts in the consolidated statements of cash flows due to unsettled share repurchases at the end of a period and excise taxes incurred on share repurchases.